Federated Hermes’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-902
Closed -$1.28K 2115
2025
Q2
$1.28K Sell
902
-2,040
-69% -$2.76K ﹤0.01% 1984
2025
Q1
$4.5K Sell
2,942
-1,350
-31% -$2.88K ﹤0.01% 1885
2024
Q4
$10.6K Sell
4,292
-9,506
-69% -$23.7K ﹤0.01% 1834
2024
Q3
$15.9K Buy
13,798
+4,259
+45% +$5.22K ﹤0.01% 1767
2024
Q2
$10.5K Buy
9,539
+1,280
+15% +$1.5K ﹤0.01% 1772
2024
Q1
$10.2K Buy
8,259
+3,676
+80% +$4.38K ﹤0.01% 1774
2023
Q4
$4.81K Buy
+4,583
New +$14K ﹤0.01% 1859
2021
Q2
Sell
-291
Closed -$7K 2194
2021
Q1
$7K Sell
291
-1,043
-78% -$20.4K ﹤0.01% 2033
2020
Q4
$9K Sell
1,334
-1,044
-44% -$4.4K ﹤0.01% 1992
2020
Q3
$6K Sell
2,378
-149
-6% -$333 ﹤0.01% 2008
2020
Q2
$4K Buy
2,527
+2,248
+806% +$3.01K ﹤0.01% 2013
2020
Q1
$1K Buy
+279
New +$380 ﹤0.01% 2065

Other funds holding ACRS